Related Experiment Video
Updated: Sep 18, 2025

Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts
Published on: August 1, 2025
SP1-Mediated Upregulation of KIF4A Promotes Prostate Cancer Progression via Targeting TWIST1
Xiaofei Liu1, Shaoke Li1, Zhi Wang1
1Department of Urology, Nanyang First People's Hospital, Nanyang, China.
Abstract:
Previous studies have found the highly expressed kinesin family member 4A (KIF4A) in various tumors, including prostate cancer. However, the role of KIF4A and its potential mechanisms in the development of prostate cancer remains unclear. Bioinformatics analysis was used to analyze the levels of KIF4A and TWIST-related protein 1 (TWIST1) based on the data from TCGA, HPA, and ENCORI databases. RT-qPCR was performed to measure the mRNA expression of KIF4A and TWIST1. The protein expression of KIF4A and specificity protein 1 (SP1) was examined through western blot analysis. CCK-8, EdU, and colony formation assay were carried out to evaluate the proliferative ability. The invasive and migrated cells were determined using the Transwell invasion assay and the wound-healing assay, respectively. EMT progress was evaluated by detecting E-cadherin and N-cadherin expression using western blot analysis. The relationship between SP1 and KIF4A was verified using ChIP and dual-luciferase reporter assay. The interaction between KIF4A and TWIST1 was confirmed through Co-IP. Animal experiments and IHC were carried out to explore the effects of KIF4A on prostate cancer mice in vivo. KIF4A was increased in prostate cancer tissues and cells, and KIF4A knockdown suppressed the proliferative, invaded, and migrated abilities, as well as EMT in DU145 and PC3 cells. The inhibition effects of SP1 knockdown on cell proliferation, invasion, migration, and EMT were harbored by overexpressing KIF4A. TWIST1 was elevated in prostate cancer and positively regulated by KIF4A. TWIST1 upregulation reversed the repressive impacts of KIF4A downregulation on prostate cancer progression. In addition, in vivo experiments and IHC assay indicated that KIF4A depletion inhibited tumor growth and EMT in mice. Our findings suggested that SP1 activated KIF4A to regulate TWIST1 expression, thereby promoting the development of prostate cancer.
Insights
Kinesin family member 4A (KIF4A) promotes prostate cancer by activating TWIST1 expression. Targeting KIF4A may inhibit tumor growth and metastasis, offering a potential therapeutic strategy for prostate cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Kinesin family member 4A (KIF4A) is highly expressed in various cancers, but its role in prostate cancer (PCa) is not fully understood.
- Investigating the mechanisms underlying KIF4A's function in PCa is crucial for developing targeted therapies.
Purpose of the Study:
- To elucidate the role and underlying mechanisms of KIF4A in prostate cancer development.
- To explore the regulatory pathway involving SP1, KIF4A, and TWIST1 in PCa progression.
Main Methods:
- Bioinformatics analysis (TCGA, HPA, ENCORI), RT-qPCR, Western blot, CCK-8, EdU, colony formation, Transwell, wound-healing assays.
- Chromatin immunoprecipitation (ChIP), dual-luciferase reporter assay, co-immunoprecipitation (Co-IP), in vivo animal experiments, and immunohistochemistry (IHC).
Main Results:
- KIF4A expression is elevated in PCa tissues and cells, promoting proliferation, invasion, migration, and epithelial-mesenchymal transition (EMT).
- SP1 activates KIF4A, which in turn upregulates TWIST1, driving PCa progression. KIF4A knockdown inhibits tumor growth and EMT in vivo.
- TWIST1 upregulation reverses the inhibitory effects of KIF4A downregulation on PCa progression.
Conclusions:
- SP1-KIF4A-TWIST1 axis promotes prostate cancer development.
- KIF4A is a potential therapeutic target for inhibiting prostate cancer progression and EMT.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Canonical Wnt Signaling Pathway
Induced Pluripotent Stem Cells
Somatic...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

